M4MM
Cronos Group Inc Reports Q2 2025 Financial Results
TORONTO – Cronos Group Inc., a Canadian cannabinoid company with an international outreach, reported its Q2 2025 financial results, showcasing a 21% year-over-year increase in net revenue, reaching $33.5 million. The growth was primarily driven ...
Cresco Labs Reports Q2 2025 Financial Results
CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...
The Cannabist Co Holdings Reports Q2 2025 Financial and Operational Results
CHELMSFORD – The Cannabist Company Holdings Inc., a leading U.S. Cannabis cultivator, manufacturer, and retailer, released its financial and operational results for the second quarter of 2025, indicating ongoing efforts to streamline operations and strengthen ...
Politics & Policy with Jeff Guillot: The Architecture of Cannabis Regulatory Frameworks
FOR IMMEDIATE RELEASE NEW YORK — Highly Capitalized Network-HCN proudly announces the launch of a new original podcast, "Politics & Policy with Jeff Guillot," dedicated to politics, legislation, and the evolving cannabis industry landscape in ...
SNDL Reports Q1 2025 Earnings
LOS ANGELES- SNDL Inc. announced its financial and operational results for the first quarter ended March 31, 2025. The company reported net revenue of CAD $204.9 million, a 3.6% increase compared to the same period ...
Cybin CEO to Discuss Medical Innovation at Milken Institute Global Conference
LOS ANGELES- Cybin Inc. a neuropsychiatry company, announced that its Chief Executive Officer, Doug Drysdale, will participate in a panel discussion at the 28th Annual Milken Institute Global Conference. The panel, titled "The Global Landscape ...
Regulatory Advances Propel Global Medical Cannabis Market Growth
LOS ANGELES- The global medical cannabis market is experiencing significant growth, driven by regulatory reforms and increased acceptance of cannabis-based therapies. According to the "Medical Marijuana - Global Strategic Business Report 2025," the market was ...
Cronos Group Inc Reports Q2 2025 Financial Results
TORONTO – Cronos Group Inc., a Canadian cannabinoid company with an international outreach, reported its Q2 2025 financial results, showcasing a 21% year-over-year increase in net revenue, reaching $33.5 million. The growth was primarily driven ...
Cresco Labs Reports Q2 2025 Financial Results
CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...
The Cannabist Co Holdings Reports Q2 2025 Financial and Operational Results
CHELMSFORD – The Cannabist Company Holdings Inc., a leading U.S. Cannabis cultivator, manufacturer, and retailer, released its financial and operational results for the second quarter of 2025, indicating ongoing efforts to streamline operations and strengthen ...
Emerald Cup Interviews: Brian Applegarth: Head of Travel & Tourism: Sunstone Winery
In this exclusive interview, sponsored by Urbana and brought to you by Highly Capitalized Network, we talk with Brian Applegarth, Head of Travel & Tourism at Sunstone Winery, live from the 20th ...
Emerald Cup Interviews: Jocelyn Sheltraw: Co-Founder & CEO: Budist
In this exclusive interview, sponsored by Urbana and brought to you by Highly Capitalized Network, we talk with Jocelyn Sheltraw, Co-Founder & CEO of Budist, live from the 20th anniversary of The ...
Emerald Cup Interviews: Marty Higgins, CEO of Urbana
In this exclusive interview, sponsored by Urbana and brought to you by Highly Capitalized Network, we talk with Marty Higgins, CEO and Founder of Urbana, live from the 20th anniversary of The ...
Emerald Cup Interviews: Candice & Chris Byers: Zen Life Organics
In this exclusive interview, sponsored by Urbana and brought to you by Highly Capitalized Network, we talk with Candice and Chris Byers of Zen Life Organics, live from the 20th anniversary of ...
